UnitedHealth Group trades around $354, after disappointing earnings and rangebound outlook

Traders Union
All News
Financial News
Unitedhealth group slips 0.42% today

Highlights

UnitedHealth Group trades at $354.57, above the 20- and 50-day moving averages but significantly below the 200-day average of $395.23, indicating lingering long-term bearish pressure.
Q2 earnings per share of $4.08 missed consensus of $4.45 despite 12.9% year-over-year revenue growth, with Stratos Investment Management cutting holdings by 35.1% and Sage Private Wealth Group increasing exposure.
The expected price range for the coming week is $344.15 to $374.97, with less than 20% probability of an upward move and increased risk of decline if support at $344 breaks.

Flow uncertainty as sentiment and positioning remain unclear

UnitedHealth Group's latest earnings report showed quarterly EPS of $4.08, missing consensus expectations of $4.45 and putting some short-term pressure on sentiment. Despite the earnings miss, the company achieved strong revenue growth of 12.9% year-over-year and maintains a market cap of $322.17 billion. Stratos Investment Management reduced its stake by 35.1% while Sage Private Wealth Group increased its holdings, reflecting continued mixed institutional positioning. Recent financial metrics, including a quick ratio of 0.85 and debt-to-equity at 0.73 as of October 17, 2025, underscore a stable capital structure.

Mixed momentum as support and resistance levels converge

The nearest dynamic support aligns with the Ichimoku Kijun at $354.41, while immediate resistance sits at the 20-day and 50-day moving averages or the round level of $360. Momentum signals are mixed. On the daily chart, MACD shows strong bullish momentum while ADX points to moderate selling pressure, indicating divergence. Daily RSI is in buy territory, but Stoch RSI suggests oversold conditions with CCI remaining neutral, so short-term signals are contradictory. BBP reads neutral, reflecting balanced intraday momentum. The stock slipped 0.42% from the previous day, with no significant opening gap, and currently trades in the middle of today’s range of $351.73 — $356.97. Volatility has been moderate, with the tone showing sideways consolidation and indecision after the open.

Downside risk favored as rangebound outlook persists

For the coming week, the expected price range is $344.15 to $374.97. The probability of an upward move is very low (less than 20%), making a decline more likely. The baseline scenario is for UNH to remain rangebound between $344 and $375, reflecting ongoing indecision. A bullish scenario would require a break above resistance near $360, targeting the weekly high. A bearish turn could be triggered by a close below $344, opening risk toward fresh lows.

Anton Kharitonov, expert at Traders Union, believes UnitedHealth Group shows short-term technical strength but faces persistent long-term bearish forces, with mixed institutional sentiment after the recent earnings miss. He sees a confluence of contradictory momentum indicators and expects continued rangebound trading between $344 and $375, with downside risk outweighing bullish prospects due to low probability of an upward breakout. "Base case remains sideways to lower — unless UNH reclaims $360 on strong volume, I remain defensive and avoid new longs."

Previously it was noted that bullish momentum diverges from overbought signals amid increased volatility in UNH shares. At that time, investors were relying on technical signals due to muted news flow and ongoing market uncertainty, as described in the discussion about bullish momentum diverges from overbought signals.

Source of Data: UNH Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.